Rapid diagnostic solutions to help you fight CVD
It’s believed that the two most common predictors for CVD are atherosclerosis and hypertension. Counseling and medicines can treat both risk factors — reducing the probability of the condition recurring or worsening, and prevent future complications.
Elevated cholesterol is one of the major risk factors for coronary heart disease, heart attack and stroke. As the blood cholesterol rises, so does the cardiovascular disease risk. Many patients, such as those with metabolic syndrome, have comorbid conditions such as high lipids and diabetes. And if other risk factors are present such as smoking, high blood pressure or diabetes, the risk increases even further.
The first step is an accurate diagnosis. Early detection is essential to cardiac care. At Abbott, we offer comprehensive cardiac solutions that are a natural fit for a wide range of outpatient settings – including physician offices, clinics, community health center, hospital and long-term care facilities, emergency rooms, and hospital outpatient clinics. Our assays and analyzers provide accurate, reliable results with rapid turnaround time, aiding clinicians in providing better patient care.
Guidelines around the world support measuring a fasting or nonfasting Lipid Panel/Cholesterol every five years in healthy adults, more regularly if you have other risk factors, in children and youths who are at an increased risk and to evaluate the success of lipid-lowering treatment.11,12,13,14
Both the Cholestech LDX™ System and the Afinion™ Lipid Panel (sold outside of the United States only) offer point-of-care testing for cholesterol and related lipids to serve as diagnostic tools that provide information for immediate risk assessment and therapeutic monitoring of heart disease and diabetes.